FDA Approves Second Blood Test for Colorectal Cancer Screening

The FDA has approved Freenome's SimpleScreen CRC blood test, offering a new screening option for average-risk adults. Clinical studies showed the test detected approximately 8 out of 10 colorectal cancers. This approval aims to increase screening uptake, as many individuals avoid traditional methods like colonoscopies or stool-based tests due to various barriers.